Covis Pharma, the maker of Makena, is planning the withdrawal after a study failed to confirm the drug works

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

The Real-Estate Market Caught in a Tangled Web of Ownership and Debt

Share Listen (2 min) This post first appeared on wsj.com

Federal Reserve credits Taylor Swift with boosting hotel revenues through blockbuster ‘Eras’ tour

Taylor Swift’s Eras Tour is boosting the U.S. economy. Ticket sales for…

Asian Americans now see why we need to fight back against racism, not ignore it

My son entered the world just days before the lockdowns and quarantines…

Working From Abroad Is the New Working From Home

ROME—The moment Jennifer Babin found out her employer’s offices in Paris wouldn’t…